Close
Smartlab Europe
Achema middle east

News

Legal, Compliance Collab Between ProductLife And EIT Health

ProductLife Group (PLG), a supplier of regulation and compliance solutions for the life sciences sector, has joined the Venture Centre of Excellence, EIT Health's regulatory hub. In order to help early-stage biotech, medtech, and digital health start-ups expedite their path...

NHS Permits Potentially Life-Saving Breast Cancer Medicine

The confidential agreement reached by the NHS and the manufacturer is expected to assist up to 1,600 women annually who have high-risk, triple-negative breast cancer. When combined with chemotherapy, pembrolizumab (trade name Keytruda®) reduces the likelihood of breast cancer...

Next ASH To Focus Bispecific Cancer Drugs And Gene Therapy

The 64th annual meeting of the American Society of Hematology, a prestigious venue for some of their field's most significant research, will be held in New Orleans in December, and blood disease specialists and medical professionals will fly there. With...

Blood Cells Generated In Lab Transfused Into First Patients

In the first clinical trial of its sort, lab-grown blood cells were administered to a second patient, potentially paving the way for future therapies for blood disorders like sickle cell. At the NHS Blood and Transplant (NHSBT) Advanced Therapies Unit...

India Wants More Access To The UK Pharma Market- Official

As a part of the proposed free trade deal with Britain, India is looking at expanding access to markets for its pharmaceutical products in the UK, an official said on November 4. The official added that a leaked chapter...

First Simulated Drug Study Examines 2 Alzheimer Treatments

The effectiveness of aducanumab and donanemab in treating Alzheimer's disease (AD) was successfully simulated using a novel computer model, demonstrating how a steady rise in dosage until reaching the maximum dose helps to minimize cognitive loss and limit adverse...

Global Pharma Morale On A New High

Pharma confidence in growth, innovation, and process efficiency has reached record highs, according to the results of the CPhI's 2022 Pharma Index poll, which were released at this year's CPhI Frankfurt. This bodes well for the industry's prospects in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »